. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Ann Surg Oncol. 2020 May 14;28(1):570–575. doi: 10.1245/s10434-020-08582-8

TABLE 2.

Outcomes of patients with primary retroperitoneal well-differentiated liposarcoma who underwent macroscopic complete (R0/R1) surgical resection (n = 88)

Patient outcomes	Median (range)
Recurrence-free survival, months	41.5 (2.0–283.5)
Recurrence	53 (60.2%)
Local	51
Sarcomatosis	1
Local and distant (lung)	1
Multifocal recurrence	28 (50%)
Histology at recurrence
WDLPS	29 (54.7%)
DDLPS + WDLPS	13 (24.5%)
Unknown	11 (20.8%)
Overall survival, months	67.2 (11.2–283.5)

DDLPS dedifferentiated liposarcoma, WDLPS well-differentiated liposarcoma